See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Natural Disasters
Social Media
Artificial Intelligence
Baseball
Soccer
Stock Markets
European Union
Apple
US Economy
Basketball
NCAA
Education
Published • loading... • Updated

Kenox Pharmaceuticals Announces Strategic Collaboration with Lactiga to Advance Mucosal-Targeted Immunotherapy

  • Kenox Pharmaceuticals Inc. And Lactiga US, Inc. Have formed a strategic collaboration to develop mucosal-targeted Secretory IgA therapies for immunodeficient patients.
  • The partnership is backed by a significant multi-million-dollar STTR grant from the National Institute of Allergy and Infectious Diseases.
  • The goal is to enhance mucosal immunity through novel therapies developed using Kenox's expertise in inhaled drug delivery.
  • Sitaram Velaga, President and CEO of Kenox, expressed excitement about the partnership, highlighting its potential impact on immunodeficient patients.
Insights by Ground AI
Does this summary seem wrong?

21 Articles

All
Left
1
Center
4
Right
3
Buffalo NewsBuffalo News
+19 Reposted by 19 other sources

Kenox Pharmaceuticals Announces Strategic Collaboration with Lactiga to Advance Mucosal-Targeted Immunotherapy

PRINCETON, N.J., March 10, 2025 /PRNewswire/ -- Kenox Pharmaceuticals Inc. and Lactiga US, Inc. are pleased to announce a strategic collaboration to advance the development of novel, groundbreaking, mucosal-targeted Secretory IgA (sIgA) therapies for immunodeficient patients. This partnership is supported…

·Buffalo, United States
Read Full Article
pressreach.compressreach.com

Kenox Pharmaceuticals Announces Strategic Collaboration with Lactiga to Advance Mucosal-Targeted Immunotherapy - PressReach

PRINCETON, N.J., March 10, 2025 /PRNewswire/ — Kenox Pharmaceuticals Inc. and Lactiga US, Inc. are pleased to announce a strategic collaboration to advance the development of novel, groundbreaking, mucosal-targeted Secretory IgA (sIgA) therapies for immunodeficient patients. This partnership is supported by a significant multi-million-dollar STTR grant awarded to Lactiga by the National Institute of Allergy and Infectious Diseases (NIAID), part …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Bradford Era broke the news in Bradford, United States on Monday, March 10, 2025.
Sources are mostly out of (0)

Similar News Topics

Princeton, New Jersey

Princeton, New Jersey

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal